TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/9/21 13:26 | 2/8/21 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldasare Bryan T | OH | O | EVP,CFO | M.d | 73 | 19.56 | 0 | 4 | 7 | 56 | D | ||||||||||||||
2/9/21 13:26 | 2/8/21 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldasare Bryan T | OH | O | EVP,CFO | S.d | -188 | 30.00 | 0 | -6 | -10 | 56 | D | ||||||||||||||
2/8/21 10:21 | 2/5/21 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldasare Bryan T | OH | O | EVP,CFO | M.d | 220 | 19.56 | 0 | 11 | 24 | 59 | D | ||||||||||||||
2/8/21 10:21 | 2/5/21 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldasare Bryan T | OH | O | EVP,CFO | S.d | -379 | 26.61 | 0 | -14 | -20 | 59 | D | ||||||||||||||
7/2/20 13:52 | 6/30/20 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldasare Bryan T | OH | O | EVP,CFO | M.d | 30 | 19.71 | 0 | 2 | 3 | 53 | D | ||||||||||||||
3/11/20 13:47 | 3/10/20 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldasare Bryan T | OH | O | EVP,CFO | P | 14 | 6.97 | 0 | 2 | 4 | 53 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |